Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00896792 · ClinicalTrials.gov registry record · Early Phase 1
Nurse Practitioner Hospice Program for Patients With Terminal Metastatic Cancer and Their Families or Caregivers
A Early Phase 1 study, sponsored by Mayo Clinic.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 26
- Enrollment target
NCT00896792: Completed Early Phase 1 study, sponsored by Mayo Clinic.
NCT00896792 is a Early Phase 1 study that has completed, run by Mayo Clinic. The registered enrollment target is 26 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00896792, a Early Phase 1 study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 26 participants
- Enrollment target
Study Summary
RATIONALE: Gathering information about patients with terminal metastatic cancer may help doctors learn more about the effectiveness of a nurse practitioner hospice program. It is not yet known whether a nurse practitioner program helps increase patients' length of stay in hospice. PURPOSE: This randomized research study is evaluating a nurse practitioner hospice program for patients with terminal metastatic cancer and their families or caregivers.
Interventions
- OTHER questionnaire administration
- OTHER survey administration
- OTHER counseling intervention
- PROCEDURE psychosocial assessment and care
- PROCEDURE end-of-life treatment/management
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2008-10-10 |
| Est. Completion | 2015-03-17 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00896792
The ClinicalTrials.gov registry entry for NCT00896792 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which questionnaire administration is the first listed.
NCT00896792 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00896792 about?
NCT00896792 is a clinical study titled "Nurse Practitioner Hospice Program for Patients With Terminal Metastatic Cancer and Their Families or Caregivers". RATIONALE: Gathering information about patients with terminal metastatic cancer may help doctors learn more about the effectiveness of a nurse practitioner hospice program. It is not yet known whether a nurse practitioner program helps increase patients' length of stay in hospice. PURPOSE: This ran...
What is the current status of trial NCT00896792?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 26 participants. The study started on 2008-10-10. Estimated completion is 2015-03-17.
What interventions are being tested in trial NCT00896792?
The interventions under investigation include: questionnaire administration (OTHER), survey administration (OTHER), counseling intervention (OTHER), psychosocial assessment and care (PROCEDURE), end-of-life treatment/management (PROCEDURE).
Who is sponsoring clinical trial NCT00896792?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.